ES2061797T3 - Mini-proinsulina, su preparacion y empleo. - Google Patents

Mini-proinsulina, su preparacion y empleo.

Info

Publication number
ES2061797T3
ES2061797T3 ES89111027T ES89111027T ES2061797T3 ES 2061797 T3 ES2061797 T3 ES 2061797T3 ES 89111027 T ES89111027 T ES 89111027T ES 89111027 T ES89111027 T ES 89111027T ES 2061797 T3 ES2061797 T3 ES 2061797T3
Authority
ES
Spain
Prior art keywords
insulin
proinsulin
mini
employment
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89111027T
Other languages
English (en)
Inventor
Michael Dr Dorschug
Paul Dr Habermann
Gerhard Dr Seipke
Eugen Dr Uhlmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2061797T3 publication Critical patent/ES2061797T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

UNA MINI - PROINSULINA EN LA QUE EN LUGAR DE LA CADENA C EL AMINOACIDO ARG PUENTEA LAS CADENAS A Y B, MUESTRA ACTIVIDAD INSULINA Y ES APROPIADA PARA LA PRODUCCION DE MEDICAMENTOS PARA ELTRATAMIENTO DE LA DIABETES MELLITUS. SE PUEDE TRANSPONER ADEMAS, SIMPLEMENTE CON TRIPSINA EN UN DERIVADO DE INSULINA CUYA CADENA B SE ALARGA EN ARG. ESTE SE PUEDE TRANSFORMAR EN INSULINA CON CARBOXIPEPTIDASA B. TAMBIEN SE PUEDE TRANSFORMAR LA MINIPROINSULINA DE FORMA VENTAJOSDA DIRECTAMENTE EN INSULINA POR UN PROCESO DE COCCION.
ES89111027T 1988-06-23 1989-06-17 Mini-proinsulina, su preparacion y empleo. Expired - Lifetime ES2061797T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3821159 1988-06-23

Publications (1)

Publication Number Publication Date
ES2061797T3 true ES2061797T3 (es) 1994-12-16

Family

ID=6357053

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89111027T Expired - Lifetime ES2061797T3 (es) 1988-06-23 1989-06-17 Mini-proinsulina, su preparacion y empleo.

Country Status (17)

Country Link
EP (1) EP0347781B1 (es)
JP (1) JP3043764B2 (es)
KR (1) KR0139629B1 (es)
AT (1) ATE101620T1 (es)
AU (1) AU611303B2 (es)
CA (1) CA1341211C (es)
DE (1) DE58906966D1 (es)
DK (1) DK175182B1 (es)
ES (1) ES2061797T3 (es)
FI (1) FI102076B (es)
HU (3) HUT52548A (es)
IE (1) IE62511B1 (es)
IL (1) IL90694A (es)
NO (1) NO302376B1 (es)
NZ (1) NZ229645A (es)
PT (1) PT90939B (es)
ZA (1) ZA894742B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4885163A (en) * 1987-02-24 1989-12-05 Eli Lilly And Company Topical use of IGF-II for wound healing
US5227293A (en) * 1989-08-29 1993-07-13 The General Hospital Corporation Fusion proteins, their preparation and use
US5358857A (en) * 1989-08-29 1994-10-25 The General Hospital Corp. Method of preparing fusion proteins
IL99383A (en) * 1990-09-05 1996-01-31 Hoechst Ag Enzymatic process for the conversion of preproinsulins into insulins
NZ245170A (en) * 1991-11-26 1994-07-26 Lilly Co Eli Insulin and proinsulin analogues with arg at b31, b32 and ao and pharmaceutical compositions
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
ATE148710T1 (de) 1992-12-02 1997-02-15 Hoechst Ag Verfahren zur gewinnung von proinsulin mit korrekt verbundenen cystinbrücken
ATE203998T1 (de) * 1993-04-27 2001-08-15 Hoechst Ag Amorphe monosphärische formen von insulinderivaten
WO1995016708A1 (en) * 1993-12-17 1995-06-22 Novo Nordisk A/S Proinsulin-like compounds
US6001604A (en) * 1993-12-29 1999-12-14 Bio-Technology General Corp. Refolding of proinsulins without addition of reducing agents
DE4405179A1 (de) * 1994-02-18 1995-08-24 Hoechst Ag Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
WO1997005166A1 (en) 1995-07-25 1997-02-13 Novartis Ag Transforming growth factor beta crystals
DE19544233A1 (de) 1995-11-28 1997-06-05 Hoechst Ag Verfahren zur Nutzung des Hefe-ADH II-Promotorsystems zur biotechnologischen Produktion heterologer Proteine in hohen Ausbeuten
PT821006E (pt) 1996-07-26 2004-09-30 Aventis Pharma Gmbh Derivados de insulina com ligacao a zinco aumentada
DE19825447A1 (de) 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
DE19915938A1 (de) * 1999-04-09 2000-10-19 Aventis Pharma Gmbh Herstellung von pankreatischer Procarboxypeptidase B, Isoformen und Muteinen davon und ihre Verwendung
EP2213743A1 (en) 2000-04-12 2010-08-04 Human Genome Sciences, Inc. Albumin fusion proteins
DE10108100A1 (de) * 2001-02-20 2002-08-29 Aventis Pharma Gmbh Verwendung supersekretierbarer Peptide in Verfahren zu deren Herstellung und paralleler Verbesserung der Exportate eines oder mehrerer anderer Polypeptide von Interesse
US7202059B2 (en) 2001-02-20 2007-04-10 Sanofi-Aventis Deutschland Gmbh Fusion proteins capable of being secreted into a fermentation medium
US7638618B2 (en) 2001-02-20 2009-12-29 Sanofi-Aventis Deutschland Gmbh Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
US7312192B2 (en) * 2001-09-07 2007-12-25 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
AU2002364586A1 (en) 2001-12-21 2003-07-30 Delta Biotechnology Limited Albumin fusion proteins
WO2005003296A2 (en) 2003-01-22 2005-01-13 Human Genome Sciences, Inc. Albumin fusion proteins
CA2514416C (en) * 2003-01-31 2012-08-14 Akzo Nobel N.V. Method for protein isolation in anoxic conditions
EP2307441B1 (en) 2008-08-07 2016-03-23 Biocon Limited A process for preparation of insulin compounds
RU2447149C1 (ru) * 2011-03-24 2012-04-10 Винсорт Менеджемент Инк РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pMSIN4, КОДИРУЮЩАЯ ГИБРИДНЫЙ ПОЛИПЕПТИД - ПРЕДШЕСТВЕННИК ИНСУЛИНА ЧЕЛОВЕКА, ШТАММ BL21(DE3)/pMSIN4-ПРОДУЦЕНТ РЕКОМБИНАНТНОГО ИНСУЛИНА ЧЕЛОВЕКА, СПОСОБ ПОЛУЧЕНИЯ РЕКОМБИНАНТНОГО ИНСУЛИНА ЧЕЛОВЕКА
WO2012152439A1 (en) 2011-05-10 2012-11-15 Glucometrix Ag Comprehensive buffer system for renaturing human proinsulin or proinsulin derivatives
CN102849910A (zh) * 2012-10-10 2013-01-02 清华大学深圳研究生院 一种从污泥中回收腐殖酸并改善污泥厌氧消化的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
DK58285D0 (da) * 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
DK129385A (da) * 1985-03-22 1986-09-23 Novo Industri As Peptider og fremstilling deraf
DK437786D0 (da) * 1986-09-12 1986-09-12 Nordisk Gentofte Insulinprecursorer
US4764592A (en) * 1987-04-23 1988-08-16 Eli Lilly And Company Crystalline human proinsulin and process for its production
US4992418A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin

Also Published As

Publication number Publication date
DK175182B1 (da) 2004-06-28
EP0347781A2 (de) 1989-12-27
KR910000796A (ko) 1991-01-30
NO892597L (no) 1989-12-27
DK309989D0 (da) 1989-06-22
HU214704B (hu) 2000-03-28
NO302376B1 (no) 1998-02-23
HK1006023A1 (en) 1999-02-05
DE58906966D1 (de) 1994-03-24
PT90939B (pt) 1994-11-30
ZA894742B (en) 1990-03-28
IL90694A0 (en) 1990-01-18
EP0347781A3 (en) 1990-05-09
FI893046L (fi) 1989-12-24
NO892597D0 (no) 1989-06-22
IE62511B1 (en) 1995-02-08
DK309989A (da) 1989-12-24
JP3043764B2 (ja) 2000-05-22
HU211552A9 (en) 1995-12-28
CA1341211C (en) 2001-03-27
NZ229645A (en) 1991-02-26
FI102076B1 (fi) 1998-10-15
IE892032L (en) 1989-12-23
KR0139629B1 (ko) 1998-07-01
FI893046A0 (fi) 1989-06-21
FI102076B (fi) 1998-10-15
HUT52548A (en) 1990-07-28
ATE101620T1 (de) 1994-03-15
IL90694A (en) 1995-07-31
AU611303B2 (en) 1991-06-06
EP0347781B1 (de) 1994-02-16
AU3671889A (en) 1990-01-04
JPH0285298A (ja) 1990-03-26
PT90939A (pt) 1989-12-29

Similar Documents

Publication Publication Date Title
ES2061797T3 (es) Mini-proinsulina, su preparacion y empleo.
ES476575A1 (es) Procedimiento para producir un articulo clulorico conformado.
GEP20012580B (en) Substituted 4-Hydroxy-Phenylalcanoic Acid Derivatives With Agonist Activity to PPAR-Gamma, Methods for Their Production, Pharmaceutical Conposition and Methods for Treatment
ES2085147T3 (es) Procedimiento para la preparacion de sales inorganicas.
DE58906676D1 (de) Ester des Retinols und/oder der Retinsäure enthaltende Aerosol-Inhalate.
DE69131589D1 (de) Ribosomen-inaktivierende Proteine, inaktive Vorläuferformen derselben, Verfahren zur Herstellung und eine Methode zur Nutzung
GB1524431A (en) Production of long acting insulin preparations
ITMI911683A1 (it) Procedimento per la produzione di alimenti complessi a lunga conservazione, pronti da consumare.
ES2061528T3 (es) Un procedimiento para preparar nuevos derivados de poliamina.
AR243605A1 (es) Un metodo para obtener protoporfirina ix del cultivo de microalgas eucarioticas del genero clamidomonas.
FI93797B (fi) Menetelmä ihmisinsuliinista ja sen johdannaisista koostuvien sekakiteiden valmistamiseksi
EP0191357A3 (en) Treatment of eye inflammation with biphenamine
DK164638C (da) Kombinationspraeparat af pyrimido-pyrimidiner og acetylsalicylsyre og/eller deres farmaceutisk acceptable salte, fremgangsmaade til dets fremstilling samt anvendelse af pyrimido-pyrimidiner og acetylsalicylsyre og/eller salte deraf sammen med farmaceutiske baerere til fremstilling af et kombinationspraeparat
PT89207A (pt) Processo para a preparcao de derivados de ciclopropano e de produtos intermediarios
ES2012736A6 (es) Procedimiento para la preparacion de derivados triciclicos de 3-oxopropanonitrilo.
MX9200977A (es) Proceso para producir l-lisina por fermentacion.
AR201790A1 (es) Metodo de cultivo para abtener una composicion que consiste en proteinas, azucares y acido lactrico, util para el tratamiento de gastritis y ulceras gastricas y duodenales
ES2127875T3 (es) Bencenosulfonil-ureas y -tioureas sustituidas con amino, procedimiento para su preparacion y su utilizacion como productos farmaceuticos.
MX26167A (es) Derivados de acido piridil-benzoico para el tratamiento de enfermedades relacionadas con lecotrino.
CO4970779A1 (es) Derivados del acido aminoetilfenoxiacetico y agentes para reducir el dolor y promover la eliminacion de calculos en urolitiasis
ES8707554A1 (es) Procedimiento para preparar interferon-a recombinante
BRPI0506694A (pt) análogos de peptìdeo-1 semelhante ao glucagon com longa duração de ação
KR900007816A (ko) 사이클로프로필-치환된 아졸릴메틸카비놀, 이의 제조방법 및 약제로서의 이의 용도
JPS645460A (en) Production of delaying gelatinous material
ES2151891T3 (es) Derivados de ciclohexano sustituidos con imidazolilo.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 347781

Country of ref document: ES